Alpha Cognition Inc (ACOG)

$ACOG Been a difficult few weeks here.

$ACOG So, earnings a week from Thursday will be extremely important.

$ACOG https://www.reddit.com/r/AlphaCognition/comments/1mhbrij/zunveyl_advancing_alzheimers_care_reducing_costs/ "Zunveyl: Advancing Alzheimer's Care & Reducing Costs in LTC (more detailed version of Friday's post)

$ACOG https://www.businesswire.com/news/home/20250804350766/en/Alpha-Cognition-to-Report-Second-Quarter-2025-Financial-Results-and-Operating-Overview The live audio webcast will be accessible here: https://viavid.webcasts.com/starthere.jsp?ei=1726104&tp_key=1b6464373d

$ACOG https://www.reddit.com/r/AlphaCognition/comments/1mf3qoa/how_alpha_cognition_zunveyl_can_help_ltc/

Caught a few of @CarlosRivera_’s plays recently dude’s been on point! If you're into trading, he's worth a follow💯 watchlist: $MWYN $NAMM $BTAI $FDMT $ACOG

$ACOG here it comes…

$ACOG I hope everyone had/has limit buy's set. I was able to increase my position by 50% over last 2 days. 08/11 cannot come fast enough

$ACOG Enough.... Let's start back up.

$ACOG https://seekingalpha.com/article/4805908-alpha-cognition-unheralded-canadian-pharma-set-to-launch-alzheimers-drug This and similar articles may be the reason why the stock has been declining somewhat for the past few days. Overall, the text is conservative and, despite everything, has upside potential. I'm waiting for a takeover here if the Q2/3 and further figures signal a significant increase.

$ACOG helps patients in long-term care (LTV) facilities live better lives for what time they have remaining ❤️

Is anyone knowledgeable about this $ACOG S-3 filed with the SEC back on July 21, 2025 and how it may have played into today's closing price of 9.25 even though the s/p reached an intra-day high of 10.09? Is anyone tracking this and is there a way to guesstimate when a majority it is fulfilled which would therefore allow the s/p to rise in a more consistent basis? https://app.quotemedia.com/data/downloadFiling?webmasterId=99084&ref=319312316&type=HTML&symbol=ACOG&cdn=491abc1e64c5c58718470d0e8b2ed0de&companyName=Alpha+Cognition+Inc.&formType=S-3&formDescription=Registration+statement+under+Securities+Act+of+1933&dateFiled=2025-07-21

Does anyone have an analysis on what happened towards the end of today with $ACOG The only news was: - “We are pleased to announce the NMPA acceptance of the ZUNVEYL New Drug Application, marking a significant milestone in our mission to bring innovative treatments to patients in need," said Michael McFadden, Chief Executive Officer of Alpha Cognition. "This acceptance reflects the strength of our partnership with CMS and the dedication of our team. We look forward to working closely with our partner throughout this important review process as we move one step closer to potentially delivering this important therapy to the Asia market." - Alpha Cognition will rely on successful regulatory and commercial expertise of CMS in the Chinese market and will benefit financially from advances in China and other Asia territories. The Company is eligible to receive regulatory, sales milestones, and royalties should ZUNVEYL be approved for marketing in China and other Asia territories. - According to the epidemiological study results published in the Lancet Public Health, there are about 7.93 million patients with mild-to-moderate Alzheimer dementia in China. With the intensifying aging trend, the number of patients and the consequent disease burden will further increase in the future. The Company anticipates additional progress across other countries with regulatory advancement and ZUNVEYL commercial approvals. I had nine orders all for 9.44/share. I had to reduce some of order quantities as a message notified me that they couldn't be placed as there wasn't sufficient shares out there. My buy orders remained unfilled until the last hour of trading then, filling all of them in quickly. The s/p continued downwards until the "At Close" s/p of 9.25. Apparently, my purchases represented approx. 10% of today's trading volume. ACOG is still very thinly traded. Surprisingly, it is possible to short ACOG. The "Available" shares to borrow for shorting purposes seems to vary between a low point of 200,000 available shares and a high point of 1,200,000 available shares between July 22nd and the 29th (today). I can't think of a reason why the s/p drifted down during the last hour with the exception of someone was selling or that it might have been a delayed effect of this July 21st SEC Form S-3: https://app.quotemedia.com/data/downloadFiling?webmasterId=99084&ref=319312316&type=HTML&symbol=ACOG&cdn=491abc1e64c5c58718470d0e8b2ed0de&companyName=Alpha+Cognition+Inc.&formType=S-3&formDescription=Registration+statement+under+Securities+Act+of+1933&dateFiled=2025-07-21 Thoughts or an analysis any one? Thanks : )

$ACOG CMS with the NDA approval moves the bar forward for another royalty payment to the company by CMS. Earnings report should reflect this as well.

$ACOG https://finance.yahoo.com/news/alpha-cognition-announces-partner-china-123000714.html

$ACOG https://xueqiu.com/3736190997/344581590 "On July 28, Kangzhe Pharmaceutical announced that the New Drug Application (NDA) for the improved new drug Zunveyl (generic name: Phengantamine Gluconate Enteric Tablets) was accepted by the State Drug Administration of China (NMPA) on July 28, 2025, and is intended for the treatment of adults with moderate to severe Alzheimer's disease symptoms. On January 8, 2025, Kangzhe Pharmaceutical, through its wholly-owned subsidiary, signed a license, cooperation, and distribution agreement with Alpha Cognition for Zunveyl. According to the agreement, Kangzhe Pharmaceutical has obtained the exclusive right to develop, register, produce, import, export, and market products in Asia (excluding Japan and the Middle East), Australia, and New Zealand, and Alpha Cognition reserves the right to produce and supply in the authorized territory."

$ACOG Great piece that accurately captures ACOG's current position. So if you want to refresh your understanding of ACOG or learn about ACOG for the first time, this is essential reading. https://beyondspx.com/article/alpha-cognition-zunveyl-s-early-momentum-fuels-path-to-profitability-nasdaq-acog

$ACOG https://article.wn.com/view/2025/07/28/Notice_of_Effectiveness_Form_EFFECT_Alpha_Cognition_Inc/

$ACOG https://www.tipranks.com/news/ratings/alpha-cognition-incs-strategic-developments-and-market-potential-drive-buy-rating-ratings

$ACOG https://www.reddit.com/r/AlphaCognition/comments/1m6c2ff/alpha_cognition_update_july_22nd_nasdaq_acog_998/ "Alpha Cognition Update - July 22nd [NASDAQ: ACOG $9.98] Alpha Cognition Inc [$160MM MCAP] is a biopharmaceuitcal stock w an FDA approved Alzheimer's drug, Zunveyl. The company will report 2nd qtr earnings (their first full quarter of sales) on Aug 14th. A Q&A with ACI on several topics: Question regarding insurance reimbursements progress & any exposure to potential cuts in medicaid: "We are getting almost all RX’s approved and Medicaid cuts will not affect the company from what we know today. We are working on improved access with the Medicare D plans and PBM’s and will be able to comment on the discussions after agreements are in place." .............click link to read more

$ACOG https://www.nasdaq.com/articles/what-makes-alpha-cognition-inc-acog-new-strong-buy-stock is from 04. July, I just saw it today

$ACOG Do it lady!